"GLP-1 medications are not appropriate for everyone, so a thorough assessment is essential," says David Braverman, assistant professor of pharmaceutical and biomedical sciences at Touro College of Pharmacy in New York City
There is more investment interest in the industry now than ever because of demand, consolidation, and awareness
For example, the EVOKE and EVOKE+ studies are exploring whether semaglutide slows Alzheimers progression in individuals without diabetes
You lose fat and that can make you look thinner, but also can make you look like youve aged, especially around your face and neck
Some scientists wonder whether low glutathione levels are at least partly to blame for the free-radical-induced illnesses so common beyond middle age, such as Alzheimers, cancer, and heart disease
Robbins N et al